← Back to Search

Cortisol Synthesis Inhibitor and Benzodiazepine Receptor Agonist

EMB-001 for Tobacco Use Disorder

Phase 1 & 2
Waitlist Available
Research Sponsored by Embera NeuroTherapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 9-12
Awards & highlights

Study Summary

This trialwill test a combo of 2 drugs to help people quit smoking. Up to 50 adults will be studied over 12 weeks.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 9-12
This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 9-12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Smoking Abstinence

Trial Design

1Treatment groups
Experimental Treatment
Group I: EMB-001 ActiveExperimental Treatment1 Intervention
720 mg metyrapone/24 mg oxazepam mg BID, for a total daily dose of 1440 mg metyrapone and 48 mg oxazepam
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EMB-001
2016
Completed Phase 2
~100

Find a Location

Who is running the clinical trial?

Foundation for a Smoke-Free WorldOTHER
9 Previous Clinical Trials
1,062 Total Patients Enrolled
2 Trials studying Tobacco Use Disorder
75 Patients Enrolled for Tobacco Use Disorder
Embera NeuroTherapeutics, Inc.Lead Sponsor
6 Previous Clinical Trials
203 Total Patients Enrolled
2 Trials studying Tobacco Use Disorder
49 Patients Enrolled for Tobacco Use Disorder
Foundation for a Smoke Free World INCOTHER
14 Previous Clinical Trials
2,133 Total Patients Enrolled
2 Trials studying Tobacco Use Disorder
75 Patients Enrolled for Tobacco Use Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this investigation allow for participation by persons aged 40 or older?

"This experiment is limited to those of between 21 and 65 years old, though there are 4 studies for minors and 76 options available for seniors."

Answered by AI

How many subjects are being recruited for this medical investigation?

"Affirmative, the entry on clinicaltrials.gov indicates that this research is actively recruiting volunteers. This trial was first published on June 10th 2021 and has been revised most recently on October 27th 2022. The investigation requires 50 test subjects to be recruited from a single location."

Answered by AI

Are there still opportunities for enrolment in this experiment?

"Clinicaltrials.gov documents demonstrate that this study is presently looking for participants, with the trial posting first appearing on June 10th 2021 and a recent update on October 27th 2022."

Answered by AI

Is it feasible for me to become a participant in this medical experiment?

"This trial is seeking 50 participants afflicted with tobacco-use disorder and aged between 21 to 65."

Answered by AI

Who else is applying?

What state do they live in?
Florida
How old are they?
18 - 65
What site did they apply to?
Rose Research Center
Embera Site
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Study of EMB-001 as a Potential Smoking Cessation Treatment
2021. "Study of EMB-001 as a Potential Smoking Cessation Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04933916.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top